103 related articles for article (PubMed ID: 6150246)
21. Experiences and results of breast cancer trials over the past 20 years at the Johannesburg Hospitals.
de Moor NG
S Afr J Surg; 1982 Sep; 20(3):215-20. PubMed ID: 6817424
[No Abstract] [Full Text] [Related]
22. Current status of post-chemotherapy tamoxifen in early breast cancer.
Tolcher AW
Oncology (Williston Park); 1994 Nov; 8(11):39-43; discussion 47-9. PubMed ID: 7826838
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant chemotherapy for operable breast cancer in postmenopausal women.
Falkson HC; Falkson G; Schoeman HS; Louw EM; Portugal MA
S Afr Med J; 1983 Jun; 63(24):917-22. PubMed ID: 6344266
[TBL] [Abstract][Full Text] [Related]
24. Management of breast cancer with hormones and drugs.
Lippman ME
Hosp Pract (Off Ed); 1986 May; 21(5):119-27, 131. PubMed ID: 3009506
[No Abstract] [Full Text] [Related]
25. The use of third-generation aromatase inhibitors and tamoxifen in the adjuvant treatment of postmenopausal patients with hormone-dependent breast cancer: evidence based review.
Poole R; Paridaens R
Curr Opin Oncol; 2007 Nov; 19(6):564-72. PubMed ID: 17906453
[TBL] [Abstract][Full Text] [Related]
26. Controlled trial of tamoxifen as adjuvant agent in management of early breast cancer. Interim analysis at four years by Nolvadex Adjuvant Trial Organisation.
Lancet; 1983 Feb; 1(8319):257-61. PubMed ID: 6130291
[TBL] [Abstract][Full Text] [Related]
27. The tamoxifen trial - a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer.
Stewart HJ; Forrest AP; Gunn JM; Hamilton T; Langlands AO; McFadyen IJ; Roberts MM
Eur J Cancer (1965); 1980; Suppl 1():83-8. PubMed ID: 7032945
[No Abstract] [Full Text] [Related]
28. Role of tamoxifen in the long-term treatment and prevention of breast cancer.
Jordan VC
Oncology (Williston Park); 1988 Sep; 2(9):19-28. PubMed ID: 3079292
[TBL] [Abstract][Full Text] [Related]
29. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant therapy for node-negative breast cancer: a proactive view.
Glick JH
Important Adv Oncol; 1990; ():183-97. PubMed ID: 2182518
[No Abstract] [Full Text] [Related]
31. The effect of adjuvant tamoxifen: the latest results from the Cancer Research Campaign Adjuvant Breast Trial. Cancer Research Campaign Breast Cancer Trials Group.
Eur J Cancer; 1992; 28A(4-5):904-7. PubMed ID: 1524921
[TBL] [Abstract][Full Text] [Related]
32. A randomised trial comparing tamoxifen vs. surgery in patients over the age of 70 with operable breast cancer--final results after 28 years of follow-up.
Gazet JC; Sutcliffe R
Eur J Surg Oncol; 2011 Sep; 37(9):754-7. PubMed ID: 21764540
[TBL] [Abstract][Full Text] [Related]
33. Symposium on the diagnosis and treatment of common cancers. 2. Adjuvant therapy of breast cancer.
Margolese RG
Can J Surg; 1983 May; 26(3):269-71. PubMed ID: 6342734
[TBL] [Abstract][Full Text] [Related]
34. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Lancet; 1998 Sep; 352(9132):930-42. PubMed ID: 9752815
[TBL] [Abstract][Full Text] [Related]
35. CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial.
Mouridsen HT; Palshof T; Engelsman E; Sylvester R
Eur J Cancer (1965); 1980; Suppl 1():119-23. PubMed ID: 7032921
[No Abstract] [Full Text] [Related]
36. Targeting adjuvant chemotherapy: a good idea that needs to be proven!
Hayes DF
J Clin Oncol; 2012 Apr; 30(12):1264-7. PubMed ID: 22355050
[No Abstract] [Full Text] [Related]
37. [Evaluation of the treatment of advanced breast cancer with tamoxifen].
Wieckowska Z
Pol Tyg Lek; 1985 Aug; 40(34):967-71. PubMed ID: 3906599
[No Abstract] [Full Text] [Related]
38. A randomised trial of mastectomy only versus tamoxifen for treating elderly patients with operable primary breast cancer-final results at 20-year follow-up.
Chakrabarti J; Kenny FS; Syed BM; Robertson JF; Blamey RW; Cheung KL
Crit Rev Oncol Hematol; 2011 Jun; 78(3):260-4. PubMed ID: 20447833
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant hormonotherapy for breast cancer.
Grem JL; Carbone PP
Eur J Cancer Clin Oncol; 1986 Mar; 22(3):235-9. PubMed ID: 3519232
[No Abstract] [Full Text] [Related]
40. Adjuvant therapy for node-negative breast cancer: a cautious interpretation.
Henderson IC
Important Adv Oncol; 1990; ():199-216. PubMed ID: 1691137
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
